Kestra Advisory Services’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,723	Closed	-$237K	–	2664
2024 Q2	$237K	Buy	1,723 +19	+1%	+$2.62K	﹤0.01%	2279
2024 Q1	$235K	Buy	+1,704	New	+$235K	﹤0.01%	2167
2023 Q1	–	Sell	-3,183	Closed	-$380K	–	2234
2022 Q4	$380K	Buy	+3,183	New	+$380K	﹤0.01%	1567